Astral Foods (JSE: ARL)
- Open
- R186.97
- Prev Close
- R184.79
- Day High
- R190.20
- Day Low
- R186.09
Key statistics
| Market cap | R7.4B |
|---|---|
| P/E | 4.6 |
| EPS | N/A |
| Div yield | 10.73% |
| 52W high | R283.90 |
| 52W low | R174.22 |
| Volume | 15K |
| Listed | N/A |
Price and fundamentals data is supplied by EODHD, with Yahoo Finance as a fallback source. Sentiment is computed by StockTalk SA from 18 live member stances recorded by registered members on this page.
What the community is sayingBullish
Astral Foods LTD (ARL) is up 2 percent to 188.63, with investors expressing positive sentiment about the stock's performance today. Multiple commenters suggest it's a good buying opportunity as the stock climbs.
Summarized from 3 posts · updated nightly
Picked up ARL at 208 on the assumption that poultry demand stays resilient through winter, but the margin pressure from feed costs means I'm sizing it smaller than usual.
ARL at R210.44 trades on a tighter P/E than Soy or Oceana, which makes sense given poultry's margin pressures lately. The dividend yield sits decent enough, but you're paying for stability rather than growth in a sector that's been grinding sideways.
ARL down half a percent today but the dividend yield is still looking tasty for a defensive play. Anyone else holding this for the income or are you more concerned about the poultry cycle headwinds?
ARL down a fraction today but the poultry cycle dynamics haven't fundamentally shifted. Revenue growth is still there if you look past the near-term margin pressure from feed costs.
ARL down 1% today but the dividend yield is still sitting around 4.5% which isn't bad for a poultry play in this economy. Anyone else holding through the noise or are you concerned about input cost pressures hitting margins again?
ARL up 0.68% to R233.05 - modest strength here, though poultry sector headwinds haven't fully eased so I'd want to see it hold above R230 before getting excited.
ARL's been grinding higher despite tough poultry economics, and at current levels the dividend yield is starting to look interesting for patient holders. The real question is whether input costs stay reasonable and the company can keep market share without constant price wars, be
ARL up 1.43% today on what looks like steady demand, but that P/E is still stretched relative to the sector average and poultry input costs remain a wild card. The dividend yield keeps it interesting for income players, though I'd need to see better margin protection before getti